Megumi Nakao

Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori

T Iwahi, Hiroshi Satoh, Megumi Nakao et al. · Antimicrobial Agents and Chemotherapy · 1991 · 278 citations · Full text

Bioorganic Chemistry, Selective Activity, Biochemistry +14

Hepatitis B virus envelope L protein particles. Synthesis and assembly in Saccharomyces cerevisiae, purification and characterization.

Shinya Kuroda, Sachiko Otaka, Takahiro Miyazaki et al. · Journal of Biological Chemistry · 1992 · 100 citations · Full text

Viral Replication, Molecular Biology, Transmembrane Proteins +20

Cefmenoxime (SCE-1365), a novel broad-spectrum cephalosporin: in vitro and in vivo antibacterial activities

KANJI TSUCHIYA, Masahiro Kondo, Makoto Kida et al. · Antimicrobial Agents and Chemotherapy · 1981 · 57 citations · Full text

Medicinal Chemistry, Antimicrobial Susceptibility, Escherichia Coli Cefmenoxime +14

TCV-116, a novel angiotensin II receptor antagonist, prevents intimal thickening and impairment of vascular function after carotid injury in rats.

Masaki Kawamura, Zen‐ichi Terashita, Hiroko Okuda et al. · Journal of Pharmacology and Experimental Therapeutics · 1993 · 51 citations

Inhibitory action of lansoprazole and its analogs against Helicobacter pylori: inhibition of growth is not related to inhibition of urease

Kumiko Nagata, E Takagi, Masataka Tsuda et al. · Antimicrobial Agents and Chemotherapy · 1995 · 49 citations · Full text

H. Pylori Urease, Pharmaceutical Science, Biochemistry +11